These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21846175)

  • 1. Drug monitoring of a case of citalopram overdosage.
    Liotier J; Coudoré F
    Drug Chem Toxicol; 2011 Oct; 34(4):420-3. PubMed ID: 21846175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of activated charcoal on citalopram-induced QT prolongation.
    Greene SC; Brooks DE; Lovecchio F
    Ann Emerg Med; 2008 Jul; 52(1):86-7; author reply 87-8. PubMed ID: 18565387
    [No Abstract]   [Full Text] [Related]  

  • 3. Should We be Worried About QTc Prolongation Using Citalopram? A Review.
    Hutton LMJ; Cave AJ; St-Jean R; Banh HL
    J Pharm Pract; 2017 Jun; 30(3):353-358. PubMed ID: 26763342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between citalopram, escitalopram and QTc prolongation in a real-world geriatric setting.
    Crépeau-Gendron G; Brown HK; Shorey C; Madan R; Szabuniewicz C; Koh S; Veinish S; Mah L
    J Affect Disord; 2019 May; 250():341-345. PubMed ID: 30877856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated charcoal decreases the risk of QT prolongation after citalopram overdose.
    Isbister GK; Friberg LE; Stokes B; Buckley NA; Lee C; Gunja N; Brown SG; MacDonald E; Graudins A; Holdgate A; Duffull SB
    Ann Emerg Med; 2007 Nov; 50(5):593-600, 600.e1-46. PubMed ID: 17719135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Citalopram, escitalopram, and the QT interval.
    Med Lett Drugs Ther; 2013 Jul; 55(1421):59. PubMed ID: 23863918
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of selective serotonin re-uptake inhibitors and the heart rate corrected QT interval in a real-life setting: the population-based Rotterdam Study.
    Maljuric NM; Noordam R; Aarts N; Niemeijer MN; van den Berg ME; Hofman A; Kors JA; Stricker BH; Visser LE
    Br J Clin Pharmacol; 2015 Oct; 80(4):698-705. PubMed ID: 25966843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citalopram, QTc Prolongation, and Torsades de Pointes.
    Tampi RR; Balderas M; Carter KV; Tampi DJ; Moca M; Knudsen A; May J
    Psychosomatics; 2015; 56(1):36-43. PubMed ID: 25619672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citalopram, QTc interval prolongation, and torsade de pointes. How should we apply the recent FDA ruling?
    Vieweg WV; Hasnain M; Howland RH; Hettema JM; Kogut C; Wood MA; Pandurangi AK
    Am J Med; 2012 Sep; 125(9):859-68. PubMed ID: 22748401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Torsade de pointes induced by citalopram and amiodarone.
    Fayssoil A; Issi J; Guerbaa M; Raynaud JC; Heroguelle V
    Ann Cardiol Angeiol (Paris); 2011 Jun; 60(3):165-8. PubMed ID: 21295285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of pharmacokinetic-pharmacodynamic modelling in management of QT abnormalities after citalopram overdose.
    Isbister GK; Friberg LE; Duffull SB
    Intensive Care Med; 2006 Jul; 32(7):1060-5. PubMed ID: 16791669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of QT prolongation with serotonin reuptake inhibitors.
    Ojero-Senard A; Benevent J; Bondon-Guitton E; Durrieu G; Chebane L; Araujo M; Montastruc F; Montastruc JL
    Psychopharmacology (Berl); 2017 Oct; 234(20):3075-3081. PubMed ID: 28770276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Torsade de pointes during combined treatment with risperidone and citalopram.
    Blaschke D; Parwani AS; Huemer M; Rolf S; Boldt LH; Dietz R; Haverkamp W
    Pharmacopsychiatry; 2007 Nov; 40(6):294-5. PubMed ID: 18030657
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetic-pharmacodynamic modelling of QT interval prolongation following citalopram overdoses.
    Friberg LE; Isbister GK; Duffull SB
    Br J Clin Pharmacol; 2006 Feb; 61(2):177-90. PubMed ID: 16433872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unintended Consequences of Adjusting Citalopram Prescriptions Following the 2011 FDA Warning.
    Gerlach LB; Kales HC; Maust DT; Chiang C; Stano C; Choe HM; Zivin K
    Am J Geriatr Psychiatry; 2017 Apr; 25(4):407-414. PubMed ID: 28012712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Citalopram Overdose: a Fatal Case.
    Kraai EP; Seifert SA
    J Med Toxicol; 2015 Jun; 11(2):232-6. PubMed ID: 25326372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics and pharmacodynamics of escitalopram in overdose and the effect of activated charcoal.
    van Gorp F; Duffull S; Hackett LP; Isbister GK
    Br J Clin Pharmacol; 2012 Mar; 73(3):402-10. PubMed ID: 21883384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QTc interval prolongation associated with citalopram overdose: a case report and literature review.
    Catalano G; Catalano MC; Epstein MA; Tsambiras PE
    Clin Neuropharmacol; 2001; 24(3):158-62. PubMed ID: 11391127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citalopram and cardiac toxicity.
    Cooke MJ; Waring WS
    Eur J Clin Pharmacol; 2013 Apr; 69(4):755-60. PubMed ID: 22996077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of QTc interval prolongation and serum level of citalopram after intoxication--a case report.
    Unterecker S; Warrings B; Deckert J; Pfuhlmann B
    Pharmacopsychiatry; 2012 Jan; 45(1):30-4. PubMed ID: 21993870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.